SCHEMBL18650334

SCHEMBL18650334

O=C(OCOC(=O)c1ccccc1)SC[C@H](NC(=O)c1ccccc1)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSL P07711 1/20 0.41
▸ ACE P12821 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ PTPN1 P18031 1/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ PPARG P37231 1/20 0.39
▸ PPARA Q07869 1/20 0.39
▸ ITGB3 P05106 1/20 0.39
▸ ITGA2B P08514 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ FOLH1 Q04609 1/20 0.39
▸ GPR132 Q9UNW8 1/20 0.39
▸ IDO1 P14902 1/20 0.39
▸ FNTA P49354 1/20 0.38
▸ FNTB P49356 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ CA2 P00918 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18631743 0.90 PPARA (0.46) ALDH1A1PPARGPPARATDP1FNTA
SCHEMBL18631777 0.89 PAM (0.42) ALDH1A1PPARGPPARATDP1TSHR
SCHEMBL18650345 0.89 ICMT (0.41) CTSLACEALDH1A1PTPN1PPARG
SCHEMBL18650343 0.88 PRSS1 (0.41) CTSLACEALDH1A1GAARAB9A
SCHEMBL18650346 0.88 PPARG (0.41) CTSLACEALDH1A1PTPN1NPC1
SCHEMBL18650367 0.86 ACE (0.40) ACEALDH1A1PPARGPPARATSHR
SCHEMBL18650341 0.85 PRSS1 (0.43) CTSLACEPPARGPPARAFNTA
SCHEMBL20122588 0.83 ACE (0.48) ACEALDH1A1PPARGPPARATDP1
SCHEMBL20122445 0.83 ADRB2 (0.41) ACEALDH1A1PPARGPPARATDP1
SCHEMBL18650369 0.82 ATM (0.46) CTSLACEALDH1A1SMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9630918-B2 Cysteine, N-acetylcysteine, and penicillamine related compounds, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2017-04-25 — — US disclosed
US-9630918-B2 Cysteine, N-acetylcysteine, and penicillamine related compounds, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2017-04-25 — — US disclosed
US-20170081280-A1 CYSTEINE, N-ACETYLCYSTEINE, AND PENICILLAMINE RELATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE Nguyen, Mark Quang (US) 2017-03-23 — — US disclosed
US-20170081280-A1 CYSTEINE, N-ACETYLCYSTEINE, AND PENICILLAMINE RELATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE Nguyen, Mark Quang (US) 2017-03-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170081280-A1 CYSTEINE, N-ACETYLCYSTEINE, AND PENICILLAMINE RELATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE NAT1, HHAT, CBS CTSL 1408/4885ACE 917/4885ALDH1A1 513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback